Back to rounds

Company profile

DIALYBRID

Dialybrid provides research, development concerning, and bio-hybrid materials for novel medical devices.

Location
Cantu, Lombardia, Italy, Europe
Website
dialybrid.com

Latest known funding

Series A round

Capital
$17.2M
Announced
Sep 22, 2026

Lead investors

Participating investors